Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06781333 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Jun 15, 2026 to Dec 15, 2027v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 1, 2025 to Apr 29, 2025
    • Site details revised
    v3
  3. Start date: Mar 1, 2025 to May 1, 2025v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to test if adding one infusion of mesenchymal stem cells to the current treatment with antipsychotic medication may help control behavioral problems in people with a diagnosis of moderate to severe Alzheimer's disease.
Trial Details
NCT Number NCT06781333
Lead Sponsor Bernard (Barry) Baumel
Conditions
(from sponsor)		 Alzheimer Disease, Agitation in Dementia
Related terms Aberrant Motor Behavior in Dementia, Aggression, Alzheimer Disease, Behavior, Psychomotor Agitation
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov